NDC 0641-6050 – Lorazepam
Lorazepam 2 mg/mL · Injection · Intramuscular, Intravenous
Product NDC0641-6050
Product details
- Brand name
- Lorazepam
- Generic name
- Lorazepam
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Marketing category
- NDA · NDA018140
- Marketed since
- July 25, 1980
- Listing expires
- December 31, 2026
- Pharmacologic class
- Benzodiazepine
Active ingredients
- Lorazepam 2 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0641-6050-10 | 10 VIAL in 1 CARTON (0641-6050-10) / 10 mL in 1 VIAL (0641-6050-01) | Jul 25, 1980 |
Recalls mentioning this NDC
- D-1309-2022 Aug 17, 2022 · Class II
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Other Lorazepam products
- 72572-380 Lorazepam 2 mg/mL · Injection · Civica, Inc.
- 65219-368 Lorazepam 2 mg/mL · Injection · Fresenius Kabi USA, LLC
- 0641-6207 Lorazepam 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6044 Lorazepam 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6045 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6046 Lorazepam 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6047 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6048 Lorazepam 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6049 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6051 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 76329-8261 Lorazepam 2 mg/mL · Injection · International Medication Systems, Limited
- 50090-5562 Lorazepam 1 mg/1 · Tablet · A-S Medication Solutions